Onward Medical N.V.
ONWRF
$4.60
-$0.39-7.82%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -3.04% | 652.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.04% | 652.10% | |||
| Cost of Revenue | -3.04% | 10.44% | |||
| Gross Profit | 3.04% | 10.17% | |||
| SG&A Expenses | -3.04% | -11.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.04% | -5.03% | |||
| Operating Income | 3.04% | 12.32% | |||
| Income Before Tax | 3.04% | 5.42% | |||
| Income Tax Expenses | -3.01% | 189.30% | |||
| Earnings from Continuing Operations | 3.04% | 2.22% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 3.04% | 2.22% | |||
| EBIT | 3.04% | 12.32% | |||
| EBITDA | 2.50% | 11.67% | |||
| EPS Basic | 3.01% | 38.03% | |||
| Normalized Basic EPS | 3.05% | 40.08% | |||
| EPS Diluted | 3.01% | 38.36% | |||
| Normalized Diluted EPS | 3.05% | 40.08% | |||
| Average Basic Shares Outstanding | 0.00% | 57.77% | |||
| Average Diluted Shares Outstanding | 0.00% | 57.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||